← Study Library
Animal · 2023
Preclinicalcounts toward this tierTargeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model
Kim J, Lee C, Han J, Jeong H, Wang S, Choi YH, Jung Y · Cells
Preclinicalcounts toward this tier
Deleting Tβ4 reduced liver injury and fibrosis by suppressing Hedgehog signalling, and putting it back restored the fibrosis — so in this organ endogenous Tβ4 drives scarring rather than preventing it.
- Population
- Conditional Tβ4-knockout mice with liver fibrosis induced by carbon tetrachloride or bile duct ligation
- Intervention
- Selective deletion of Tβ4 in activated hepatic stellate cells; re-expression by adeno-associated virus
- Comparator
- Littermate controls
- Limitations
- Hepatic stellate cells specifically; other groups report Tβ4 inhibiting stellate-cell activation, so the liver literature is itself split.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental